Another concern is about medications with which CBD might interact. This won’t be an issue with most drugs, says Sunil Kumar Aggarwal, M.D., Ph.D., a palliative medicine physician and scientist who studies cannabis and integrates it into his Seattle medical practice. The exceptions are blood thinners, IV antibiotics, and other drugs whose exact dosing is crucial and must be monitored closely, he says. (Of course, if you have a health problem, talk to your doctor before using CBD, and never take it instead of seeing your physician for a serious condition.)

Lab techs use state of the art equipment to create phase changes in carbon dioxide by utilizing temperature and pressure. The carbon dioxide is cooled and compressed to upwards of 10,000 psi – by comparison your car tire is pressurized to about 300 psi. When compressed to these extremes, CO2 becomes ‘supercritical’, which simply means that it converts to liquid when placed under extreme pressure.


CBD isolate is pure CBD, extracted and purified until none of the plant’s other constituent compounds remain. It has been isolated down to just the CBD molecule. This purity and potency is why it’s the preferred treatment for patients needing unadulterated doses of CBD and nothing else. It has no other active ingredients and its purpose is simply to deliver therapeutic doses of CBD. CBD isolate products often come as a white powder or a mix with a oil.

CBD isolate is pure CBD, extracted and purified until none of the plant’s other constituent compounds remain. It has been isolated down to just the CBD molecule. This purity and potency is why it’s the preferred treatment for patients needing unadulterated doses of CBD and nothing else. It has no other active ingredients and its purpose is simply to deliver therapeutic doses of CBD. CBD isolate products often come as a white powder or a mix with a oil.

Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160
×